GL-V9 synergizes with oxaliplatin of colorectal cancer via Wee1 degradation mediated by HSP90 inhibition.
Hongyu ChenFan YangQianying ZhaoHongzheng WangMengyuan ZhuHui LiZheng GeShuai ZhangQinglong GuoHui HuiPublished in: The Journal of pharmacy and pharmacology (2024)
Collectively, our findings revealed that GL-V9 synergized with oxaliplatin to suppress CRC and displayed a promising strategy to improve the efficacy of oxaliplatin.
Keyphrases